Has Naresh Mori, MD received payments from drug or device companies?

Yes. Drug and device makers reported $408,365 in general payments to Naresh Mori, MD across 190 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Naresh Mori, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Naresh Mori, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Naresh Mori, MD

Cardiovascular Disease · Rock Hill, SCNPI 1629281282

Payments from drug & device makers

$408,365in general payments, 2019–2025

Across 190 payments — averaging $2149.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Astrazeneca UK Limited$322K
Ionis Pharmaceuticals, Inc.$47K
AstraZeneca$31K
Philips North America LLC$1K
Boston Scientific$905
Abbott$641
plus $5K from 39 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Astrazeneca UK Limited	2	$322,005
Ionis Pharmaceuticals, Inc.	10	$47,314
AstraZeneca	11	$31,305
Philips North America LLC	6	$1,042
Boston Scientific	11	$905
Abbott	11	$641
Edwards Lifesciences	4	$427
Johnson & Johnson	15	$373
Bayer	6	$302
Penumbra, Inc.	2	$285
Teleflex LLC	2	$278
Abiomed	6	$273
Novartis	14	$270
Cardiovascular Systems Inc.	4	$262
Actelion Pharmaceuticals US, Inc.	4	$256
E.r. Squibb & Sons, L.L.C.	12	$224
Amarin Pharma, Inc.	8	$221
Boehringer Ingelheim	4	$170
Merck	8	$164
Scpharmaceuticals Inc.	2	$153
Atricure, Inc.	2	$150
Biotronik Inc.	3	$145
Inspire Medical Systems, Inc.	1	$140
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	2	$123
Kiniksa Pharmaceuticals International, PLC	1	$123
Novo Nordisk	1	$121
Cardiva Medical, Inc.	7	$99
Organogenesis Inc.	1	$79
Pfizer	5	$70
Cvrx, Inc.	2	$54
Sanofi-aventis U.S. LLC	3	$50
Tactile Systems Technology Inc	2	$49
Lexicon Pharmaceuticals, Inc.	3	$47
Amgen	2	$35
Kestra Medical Technology Services, Inc.	2	$33
Kowa Pharmaceuticals America, Inc.	2	$30
Daiichi Sankyo Inc.	1	$27
Jazz Pharmaceuticals Inc.	1	$19
Terumo Medical Corporation	1	$19
Alnylam Pharmaceuticals Inc.	1	$18
Cleerly, Inc.	1	$16
Chiesi USA, Inc.	1	$15
Bard Peripheral Vascular, Inc.	1	$13
Gilead	1	$11
Thrombolex, Inc.	1	$9

How this compares

$408,365 in reported general payments places this provider in the 95th percentile of 257 cardiovascular disease providers in South Carolina.

See all cardiovascular disease providers in South Carolina →

Medicare billing

Part B allowed, 2024

$1,045,613

Medicare patients

1,595

Services billed

7,217

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in Rock Hill

Pradeep SinghRock Hill$73K
Sushil SinghiRock Hill$55K
James MaherRock Hill$45K
Murad AbdelsalamRock Hill$21K
Brent McLaurinAnderson$1.1M
Robert BiedermanCharleston$801K
James MerriamGreenville$728K
Vipul ShahLancaster$488K
Arthur EberlyGreenville$438K
Gregory SanGreenville$429K

See the full list for South Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →